Coverage of Second Dose of Measles-Containing Vaccine (MCV-2) and Japanese Encephalitis Vaccine (JE-2) and Its Predictors Among Children 2-5 Years Old in the Ormanjhi Block of Ranchi, Jharkhand, India: A Mixed Method Study

• Published in: Curēus (Palo Alto, CA) CA), 2024-11, Vol.16 (11), p.e73004
• Main Authors: Mukul, Ankita, Singh, Shashi B, Sagar, Vidya, Paswan, Dilip K, Narain, Smiti, Kumar, Dewesh
• Format: Article
• Language: English
• Subjects: Pediatrics; Preventive Medicine; Public Health
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.73004

Introduction Administering the measles vaccine at an appropriate age and dosage in children is important for India to eliminate measles, a potentially deadly vaccine-preventable disease. Similarly, the Japanese encephalitis (JE) vaccine, particularly in endemic regions is important to prevent morbidity and high-case fatality from the disease. The study attempts to evaluate the coverage of measles and JE vaccines and their predictors. Materials and methods A mixed method study design, incorporating a three-stage cluster random sampling process was used in the cross-sectional survey conducted among 604 children aged 2-5 years in the Ormanjhi block of Ranchi, Jharkhand, from April 2023 to June 2024. The parents/caregivers of the eligible children were interviewed using a predesigned, pretested semi-structured questionnaire, and the immunization status of children was taken from vaccination cards. A focused group discussion (FGD) and an in-depth interview (IDI) with healthcare providers formed the qualitative component. We conducted descriptive, and logistic regression analysis using the IBM SPSS Statistics for Windows, Version 26 (Released 2019; IBM Corp., Armonk, New York, United States). The association between the coverage of the vaccine and sociodemographic variables was done using the Chi-square test. Logistic regression was used to study the predictors, and a p-value of